SCHEMBL3081144

SCHEMBL3081144

CC(C)C(=O)OCC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7874498 0.82
SCHEMBL16808726 0.82
SCHEMBL11652702 0.81 TSHR (0.34)
SCHEMBL30902191 0.81 TSHR (0.34)
SCHEMBL11652697 0.81 TSHR (0.34)
Hydrochloric Acid SCHEMBL31249825 0.80 GRIN2D (0.36)
SCHEMBL11194617 0.80
SCHEMBL1218428 0.79
SCHEMBL27773901 0.78
SCHEMBL17866516 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506175-B1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2009-04-01 EP claimed
US-7196110-B2 N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders JANSSEN PHAMACEUTICA N.V. (BE) 2007-03-27 US claimed
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP claimed
US-20040082639-A1 N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders JANSSEN PHARMACEUTICA, N.V. (BE) 2004-04-29 US claimed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO claimed
US-4873362-A REACTING AN ACYLOXYACETALDEHYDE WITH AN ALDEHYDE USING AN AMINE AND ACID CATALYST SYSTEM BASF AKTIENGESELLSCHAFT (DE) 1989-10-10 US claimed
EP-3538539-B1 STEROIDS AND PROTEIN-CONJUGATES THEREOF REGENERON PHARMA (US) 2025-08-27 EP disclosed
CN-114423752-B Non-hygroscopic crystalline salts of pyrazole compounds, pharmaceutical compositions and uses thereof 耶路撒冷希伯来大学伊萨姆研究发展公司 2025-06-24 CN disclosed
US-12092648-B2 Detection of glucuronidated and 3-bromotyrosine THE CLEVELAND CLINIC FOUNDATION (US) 2024-09-17 US disclosed
CN-117916215-A Indene compound, pharmaceutical composition thereof and therapeutic application thereof 藤济(厦门)生物医药科技有限公司 2024-04-19 CN disclosed
CN-116472034-A Indene compound, pharmaceutical composition thereof and therapeutic application thereof 藤济(厦门)生物医药科技有限公司 2023-07-21 CN disclosed
CN-115916154-A Osmotic dosage forms comprising deutetrabenazine and methods of use thereof 奥斯佩克斯医药公司 2023-04-04 CN disclosed
CN-114989140-A Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer 卡佩拉医疗公司 2022-09-02 CN disclosed
CN-1331580-A Conversion of liquid-filled gelatin capsules into controlled release systems with multiple coatings ALZA CORP (US) 2002-01-16 CN disclosed
CN-1325301-A Controlled delivery of active agents ALZA CORP (US) 2001-12-05 CN disclosed
US-4873362-A REACTING AN ACYLOXYACETALDEHYDE WITH AN ALDEHYDE USING AN AMINE AND ACID CATALYST SYSTEM BASF AKTIENGESELLSCHAFT (DE) 1989-10-10 US disclosed
EP-0273314-A2 Process for the preparation of acyloxyacetaldehydes HOECHST AKTIENGESELLSCHAFT (DE) 1988-07-06 EP disclosed
US-4331728-A Laminate made of a cellulose acetate layer and an elastomeric material layer ALZA CORPORATION (US) 1982-05-25 US disclosed
US-4203439-A Osmotic system with volume amplifier for increasing amount of agent delivered therefrom ALZA CORPORATION (US) 1980-05-20 US disclosed
US-4036228-A Osmotic dispenser with gas generating means ALZA CORPORATION (US) 1977-07-19 US disclosed